Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond Miller

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
BMJ Case Reports|November 24, 2022
Metastatic spread of serous ovarian carcinoma to the bilateral breasts: a rare presentationArif Musa, Michael Joiner, Stephen Dzul, et al.
BMJ Case Reports|June 19, 2023
High grade leiomyosarcoma of the transverse colon with positive lymph node metastasis: to treat or not to treat with adjuvant radiation therapy?Phillip Jenkins, Michael Joiner, Andrew Kumar, et al.
SAGE Open Medical Case Reports|August 26, 2024
Complete radiographic response after proton radiation therapy in the re-irradiation of a diffuse high-grade glioma: A case reportJacfar Hassan, Christian Hyde, Michael Joiner, et al.
Journal of Clinical Pharmacology|April 8, 2014
Population pharmacokinetic-pharmacodynamic modeling analysis of intrinsic FXa and bleeding from edoxaban treatmentSaeHeum Song, Dongwoo Kang, Abdel-Baset Halim, et al.
BMJ Case Reports|July 18, 2023
Adenocarcinoma involving the urinary bladderPule Wang, Michael Joiner, Stephen Dzul, et al.
Journal of Clinical Pharmacology|July 4, 2015
Population pharmacokinetic modeling and simulation for assessing renal impairment effect on the pharmacokinetics of mirogabalinOphelia Q P Yin, Domenico Merante, Kenneth Truitt, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 11, 2007
Mixed effects modeling of weight change associated with placebo and pregabalin administrationBill Frame, Stuart L Beal, Raymond Miller, et al.
Journal of Clinical Pharmacology|June 16, 2015
Exposure-response modeling of average daily pain score, and dizziness and somnolence, for mirogabalin (DS-5565) in patients with diabetic peripheral neuropathic painMatthew M Hutmacher, Bill Frame, Raymond Miller, et al.
Journal of Clinical Pharmacology|May 14, 2015
Population pharmacokinetics of edoxaban and its main metabolite in a dedicated renal impairment studySiv Jönsson, Ulrika S H Simonsson, Raymond Miller, et al.
Journal of Clinical Pharmacology|June 8, 2011
Modeling longitudinal daily seizure frequency data from pregabalin add-on treatmentJae Eun Ahn, Elodie L Plan, Mats O Karlsson, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
BMJ Case Reports|November 24, 2022
Metastatic spread of serous ovarian carcinoma to the bilateral breasts: a rare presentationArif Musa, Michael Joiner, Stephen Dzul, et al.
BMJ Case Reports|June 19, 2023
High grade leiomyosarcoma of the transverse colon with positive lymph node metastasis: to treat or not to treat with adjuvant radiation therapy?Phillip Jenkins, Michael Joiner, Andrew Kumar, et al.
SAGE Open Medical Case Reports|August 26, 2024
Complete radiographic response after proton radiation therapy in the re-irradiation of a diffuse high-grade glioma: A case reportJacfar Hassan, Christian Hyde, Michael Joiner, et al.
Journal of Clinical Pharmacology|April 8, 2014
Population pharmacokinetic-pharmacodynamic modeling analysis of intrinsic FXa and bleeding from edoxaban treatmentSaeHeum Song, Dongwoo Kang, Abdel-Baset Halim, et al.
BMJ Case Reports|July 18, 2023
Adenocarcinoma involving the urinary bladderPule Wang, Michael Joiner, Stephen Dzul, et al.
Journal of Clinical Pharmacology|July 4, 2015
Population pharmacokinetic modeling and simulation for assessing renal impairment effect on the pharmacokinetics of mirogabalinOphelia Q P Yin, Domenico Merante, Kenneth Truitt, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 11, 2007
Mixed effects modeling of weight change associated with placebo and pregabalin administrationBill Frame, Stuart L Beal, Raymond Miller, et al.
Journal of Clinical Pharmacology|June 16, 2015
Exposure-response modeling of average daily pain score, and dizziness and somnolence, for mirogabalin (DS-5565) in patients with diabetic peripheral neuropathic painMatthew M Hutmacher, Bill Frame, Raymond Miller, et al.
Journal of Clinical Pharmacology|May 14, 2015
Population pharmacokinetics of edoxaban and its main metabolite in a dedicated renal impairment studySiv Jönsson, Ulrika S H Simonsson, Raymond Miller, et al.
Journal of Clinical Pharmacology|June 8, 2011
Modeling longitudinal daily seizure frequency data from pregabalin add-on treatmentJae Eun Ahn, Elodie L Plan, Mats O Karlsson, et al.
Pageof 5